Oral antithrombotics for stroke episode

A dataset of 16 trials comparing seven oral antithrombotics with each other and placebo in patients with atrial fibrillation. The analysed binary outcome is prevention of a stroke episode.

Usage

data(nma.dogliotti2014)

Format

A data frame with 16 rows of arm-based data and 13 columns (maximum number of 3 arms).

Source

Dogliotti A, Paolasso E, Giugliano RP. Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79808 patients. Heart 2014;100(5):396–405. doi: 10.1136/heartjnl-2013-304347

Details

The interventions have been coded as follows: 1, placebo; 2, aspirin; 3, aspirin plus clopidogrel; 4, dabigatran 110 mg; 5, dabigatran 150 mg; 6, rivaroxaban; 7, vitamin K antagonist; and 8, apixaban